Accel has 58 tracked deals to ARCH Venture Partners's 20. Stage focus, check size, and sector fit compared side by side.
Accel is an active investor with 58 tracked deals. ARCH Venture Partners is an active investor with 20 tracked deals. Accel shows 38 more tracked rounds than ARCH Venture Partners in this dataset, which is the clearest signal of deployment pace between the two. Recent tracked names include Alyssum Therapeutics and Anysphere for Accel and AIRNA and Altido Therapeutics for ARCH Venture Partners.
Investors like Accel · Investors like ARCH Venture Partners · Accel co-investors · Full investor directory